Loading company…
ID 406339859 · FY 2023–2024 · 2 years
ძირითად საქმიანობას წარმოადგენს მედიკამენტების და ბიოლოგიურად აქტიური დანამატების იმპორტი და საბითუმო რეალიზაცია.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2023 | 2024 | CAGR |
|---|---|---|---|
| Total Current Assets | 2,902 | 3,217 | +10.8% |
| Total Non-Current Assets | 1 | 28 | +1891.6% |
| TOTAL ASSETS | 2,904 | 3,245 | +11.7% |
| Total Current Liabilities | 0 | 0 | |
| Total Non-Current Liabilities | 3,057 | 3,411 | +11.6% |
| TOTAL LIABILITIES | 3,057 | 3,411 | +11.6% |
| Total Equity | -153 | -166 | +8.4% |
| Balance Check (Assets - L&E) | 0 | 0 | |
| Debt analysis | |||
| Total Debt | 3,044 | 3,399 | +11.7% |
| Cash & Equivalents | 13 | 37 | +182.1% |
| Net Debt | 3,031 | 3,362 | +10.9% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.